CYH33
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CYH33, covering 2025-04-22 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma [Phase 2]